Brain Infarction Clinical Trial
Official title:
Small Cortical Cerebellar Infarctions Are Associated With Patent Foramen Ovale in Young Cryptogenic Stroke Patients
The investigator retrospectively analyzed consecutive young (<60 years) cryptogenic stroke patients with Patient Foramen Ovale (PFO) recruited between January 2016 and May 2019 in our center, and compared these patients with sex- and age-matched controls with cryptogenic stroke without PFO. Analyzed baseline characteristics: sex, age, cardiovascular risk factors, history of stroke, and cortical/subcortical localization, arterial territory, number of lesions, and lesion size of the acute symptomatic infarction, together with the ROPE score. The presence and the number of acute and chronic SCCI lesions were assessed.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01977456 -
Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke (CLEAR-FDR)
|
Phase 2 | |
Completed |
NCT01915368 -
Determining Optimal Post-Stroke Exercise (DOSE)
|
N/A | |
Recruiting |
NCT01561677 -
Consequences of Obstructive Sleep Apnea Syndrome (OSAS) After Ischemic Subtentorial Stroke.
|
N/A | |
Terminated |
NCT00141011 -
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
|
Phase 3 | |
Completed |
NCT02684825 -
Detection of Silent Atrial Fibrillation aFter Ischemic StrOke
|
N/A | |
Completed |
NCT00829361 -
Stroke Telemedicine for Arizona Rural Residents Trial
|
N/A | |
Recruiting |
NCT04908241 -
Telerehabilitation With Aims to Improve Lower Extremity Recovery Post-Stroke (TRAIL-RCT)
|
N/A | |
Recruiting |
NCT01934725 -
Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Etiology, Triggers, and Outcome
|
||
Terminated |
NCT01059149 -
Safety and Long-term Effectiveness of High Frequency Repetitive Transcranial Magnetic Stimulation of Stroke (RAICup)
|
Phase 2 | |
Recruiting |
NCT05068349 -
For Patients With Ischemic Stroke, Clinically Study the Effectiveness and Safety of Butylphthalide.
|
Phase 4 | |
Completed |
NCT05086874 -
Using Real-world Evidence to Analyze the Clinical Effects and Adverse Events of Butylphthalide in Stroke Patients
|
||
Completed |
NCT00126516 -
Angiotensin II Receptor Blockers (ARB) and ACE Inhibitors (ACEI) on Silent Brain Infarction and Cognitive Decline
|
Phase 4 | |
Completed |
NCT02389894 -
Neuroprotection in Patients Undergoing Aortic Valve Replacement
|
N/A | |
Terminated |
NCT00300196 -
ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
|
Phase 3 | |
Completed |
NCT00871715 -
Arm Rehabilitation Study After Stroke
|
N/A | |
Completed |
NCT04265664 -
Telerehabilitation With Aims to Improve Lower Extremity Recovery Post-Stroke
|
N/A | |
Completed |
NCT00894803 -
Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke
|
Phase 2 | |
Active, not recruiting |
NCT00657969 -
Looking For Genetic and Environmental Risk Factors and Therapeutic Aspects in Cervical Artery Dissections
|
N/A | |
Completed |
NCT05169450 -
Efficacy of Diterpene Ginkgolides Meglumine Injection in Elderly Patients With Ischemic Stroke
|
N/A | |
Not yet recruiting |
NCT03318744 -
Antiplatelet Therapy for Silent Brain Infarction
|
N/A |